Comparison
Memantine vs Semax
NMDA antagonist for tolerance and rumination vs. neurotrophic peptide for clean focus and mood support.
Memantine
NMDA Receptor Antagonist
Semax
Melanocortin Neuropeptide
Effectiveness Profile
At a Glance
| Memantine | Semax | |
|---|---|---|
| Type | Nootropic | Nootropic |
| Legal status | Rx-Only | Research |
| Half-life | 60–80 hours | Plasma ~5 min; CNS effect 20–24 hours |
| Preferred route | Oral | Intranasal |
| Dose frequency | once-daily | twice-daily |
| Beginner dose | 2.5–5 mg | 300–600 mcg |
| Intermediate dose | 10–20 mg | 600–1200 mcg |
| Advanced dose | 20–30 mg | 1200–2000 mcg |
| Cycle length | 4–52 wks | 2–4 wks |
| Bioavailability | 100% | 70% |
| Time to peak | 5h | 0.5h |
| Active duration | 24h | 22h |
| Storage | Room temperature, 20–25°C, in a dry sealed container away from light | 2–8°C refrigerated; discard reconstituted solution after ~30 days |
| PCT required | No | No |
| Ancillaries required | No | No |
| Safe for women | Yes | Yes |
Verdict
Memantine wins for modulating glutamatergic tone, reducing stimulant or kratom tolerance, and augmenting OCD-spectrum protocols without sedating or flattening normal cognition. It excels when the goal is to mitigate tolerance or curb pathological rumination, especially in multi-compound neuro stacks, with a long half-life ensuring stable plasma levels but gradual onset.
Semax wins for rapid-onset, side-effect-light cognitive and mood enhancement, BDNF-driven neuroprotection, and acute focus without catecholamine fatigue or drive blunting. Its intranasal delivery and very clean subjective profile make it the go-to for on-demand focus, stress support, and recovery from cognitive fatigue, especially when cycling off or minimizing stimulants.
Pick A or B?
Pick Memantine if:
- Tolerance to stimulants (e.g., amphetamines, modafinil) or kratom is rising and sustained attenuation is needed
- Research requires NMDA antagonism for neuroprotection without dissociation or cognitive fog
- Augmenting SSRI or OCD-spectrum protocols to lower compulsive checking, rumination, or BDD-adjacent thought loops
- The goal is steady-state anxiolysis without the rebound or sedation of benzos or GABAergics
- A protocol favors oral, once-daily, long-acting compounds over acute/episodic dosing
Pick Semax if:
- Acute, clean cognitive lift and focus are needed without stimulant-like crash or jitter
- BDNF/NGF upregulation is desired for neuroplasticity, recovery, or long-term cognitive resilience
- On-cycle mood support is needed without SSRI/SNRI blunting or GABAergic impairment
- Protocols require rapid onset and flexible intranasal dosing (hours, not days)
- Seeking neuroprotection or cognitive recovery (e.g., post-concussive, stress/fatigue scenarios), especially where cortisol elevation is contraindicated
